Attachment_7_-_Sample_Client_Authorization_Letter.pdf
PDF 17 KB Posted
- Solicitation number
- FDA-SOL-1153590
About this file
Attachment 7 - Sample Client Authorization Letter
View the file
Other files
Show all 16
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA-SOL-1153590 ATTACHMENT 7
SAMPLE CLIENT AUTHORIZATION LETTER
(Transfer to Company Letterhead)
Dear Client, We are currently responding to Solicitation Number FDA-SOL-1153590 for On-site Animal Husbandry, Animal Care and Technical Support Services for the FDA’s Animal Care and Use Programs (ACUP), specifically the CBER/CDER/CDRH White Oak Consolidated Animal Program (WOC AP) and the CFSAN Muirkirk Road Complex (MRC/MOD-1) Program. The White Oak Complex is located in Silver Spring, MD and the Muirkirk Road Complex is located in Laurel MD.
The FDA placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitations be identified and their participation in the evaluation process be requested.
Therefore, enclosed is a Present and Past Performance Questionnaire for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration at the following address:
Food and Drug Administration Jefferson Laboratories Complex National Center for Toxicological Research Division of Acquisition Programs Field Operation Branch, HFT-320 Attn: Suzanne Martella 3900 NCTR Road, Bldg 50, Rm 430 Jefferson, AR 72079
Respondents may also fax the questionnaire to Suzanne Martella at 870-543-7990 or submit by email to suzanne.martella@fda.hhs.gov. Questionnaires must be received at the Agency no later than November 10, 2016.
If you have questions or require assistance regarding the attached questionnaire, please contact Suzanne Martella, FDA Contract Specialist, at 870-543-7540 or at suzanne.martella@fda.hhs.gov .
We thank you for your prompt response in this matter.
Sincerely, {Offering Entity} mailto:suzanne.martella@fda.hhs.gov mailto:suzanne.martella@fda.hhs.gov
File details come from the government source that posted it. Updated .